The Ohio State University Wexner Medical Center is a multidisciplinary academic medical center located in Columbus, Ohio, United States, on the main campus of The Ohio State University.

There are 2,260 beds in Ohio State Univ Hosp Clinic.

During the past decade, Ohio State Univ Hosp Clinic conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ohio State Univ Hosp Clinic" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 47 trials, followed by "Pfizer" with 6 trials sponsored, "The George Washington University Biostatistics Center" with 6 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "AIDS Clinical Trials Group" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ohio State Univ Hosp Clinic" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 7 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator, "Glaxo Wellcome" with 3 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Ohio State Univ Hosp Clinic" are "HIV Infections" (64 trials), "Candidiasis, Oral" (4 trials), "Lipodystrophy" (3 trials), "Meningitis, Cryptococcal" (3 trials) and "Histoplasmosis" (2 trials). Many other conditions were trialed in "Ohio State Univ Hosp Clinic" in a lesser frequency.

Most popular intervention types in "Ohio State Univ Hosp Clinic" are "Drug" (71 trials), "Device" (8 trials), "Other" (4 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (18 trials), "Didanosine" (10 trials), "Indinavir sulfate" (9 trials), "Efavirenz" (8 trials) and "Stavudine" (8 trials). Other intervention names were less common.

The vast majority of trials in "Ohio State Univ Hosp Clinic" are 87 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Ohio State Univ Hosp Clinic". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 75 completed trials in Ohio State Univ Hosp Clinic, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ohio State Univ Hosp Clinic, 6 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 23 trials that are defined as “Not Applicable".